Atlas Trials

Peripheral T-Cell Lymphoma, Not Otherwise Specified

18 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Peripheral T-Cell Lymphoma, Not Otherwise Specified

RecordFirmDate
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma (NCT04803201)Alliance for Clinical Trials in Oncology2021-10-08
Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma (NCT03590574)Autolus Limited2018-08-30
Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms (NCT03493451)BeiGene2018-04-13
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma (NCT03113500)City of Hope Medical Center2017-05-25
Risk Stratification of Nodal PTCL (NCT03040206)Chonbuk National University Hospital2017-01-01
Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma (NCT02652715)Mayo Clinic2016-01-19
Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma (NCT02561273)University of Nebraska2015-09-28
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency (NCT01787409)Mayo Clinic2013-03-06
Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma (NCT00901147)Singapore General Hospital2009-11-01

Track Peripheral T-Cell Lymphoma, Not Otherwise Specified automatically

Every clearance here is in the API, with alerts when new ones post.